Use of type 4 phosphodiesterase inhibitors in myocardial diseases

Details for Australian Patent Application No. 2002228047 (hide)

Owner MERCK PATENT GMBH

Inventors Sutter, Arne; Wilm, Claudia; Eggenweiler, Hans-Michael; Leibrock, Joachim; Minck, Klaus; Welge, Thomas; Wolf, Michael; Beier, Norbert; Schelling, Pierre; Ehring, Thomas; Gassen, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2002228047

PCT Pub. Number WO2002/072103

Priority 01119875.1 17.08.01 EP; 01102811.5 12.02.01 EP

Filing date 15 January 2002

Wipo publication date 24 September 2002

International Classifications

A61K 031/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 031/50 - Pyridazines

A61P 009/00 Drugs for disorders of the cardiovascular system

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002228047

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228048-Urea derivatives as integrin alpha 4 antagonists

2002228046-CATALYTIC PRECIOUS METALTREATED CARBON BLACK